
Keywords: ACE; angiotensin-converting enzyme; CAD; coronary artery disease; CMR; cardiovascular MRI; CRP; C-reactive protein; IVS; interventricular septum; JMHW; Japanese Ministry of Health and Welfare; LGE; late gadolinium enhancement; LGE-CMR; late gadolinium enh